In Cox regression model of univariate analysis, older age, poorer liver function reserve, higher AFP level, tumor with macrovascular invasion (MVI), having no disease control, no combination therapy with regorafenib or nivolumab, and no post-regorafenib or nivolumab therapy were independent risk factors associated with mortality (Table 3). The gene discussed is AFP; the disease is neoplasm.